Developer docs
API playgroundTry for free, no card

Search company profiles

Symphony Robotics

Full company profile

uuid002zshi

Namestring
Symphony Robotics
Legal namestring
Symphony Robotics
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Symphony Robotics is a Miami-based, privately held medical device company developing an MRI-guided, magnetically actuated micro-robotic platform for neurosurgical applications. The company's core product is described as the world's first MRI-guided steerable micro-robotic system capable of navigating the brain along non-linear, snake-like trajectories, controlled by AI algorithms. The flexible robotic arm is designed to bend, steer, and maneuver through complex brain anatomy to reach lesions previously considered inaccessible via conventional rigid surgical instruments, enabling energy delivery, biopsies, and targeted therapeutic agent delivery through a single minimally invasive entry point. The platform targets neurosurgeons and brain surgery centers treating patients with irregularly shaped or hard-to-reach brain pathologies, including brain tumors and drug-resistant epilepsy.

The technology remains investigational and has not been cleared or approved by the U.S. Food and Drug Administration. The company has been validated through more than a decade of research and has received over $12 million in cumulative non-dilutive grant funding from the National Institutes of Health (NIH) and National Science Foundation (NSF). In October 2025, Symphony Robotics entered a strategic partnership with Monteris Medical to combine its MRI-guided micro-robotic arm with Monteris' NeuroBlate laser interstitial thermal therapy (LITT) system for treating brain tumors and drug-resistant epilepsy. The company is led by Founder and CEO Mordechai Avisar and Chief Medical Officer Neil Martin, with a headcount of 1-10 employees.

The business model is pre-commercial. Once FDA clearance is obtained, Symphony Robotics is expected to generate revenue primarily through direct enterprise sales of its micro-robotic platform hardware to hospitals and neurosurgical centers, with potential supplemental revenue from training, implementation, and technical support services. Distribution will likely be executed through direct sales to major neurosurgical centers, with the Monteris Medical partnership potentially providing an additional channel via NeuroBlate's installed base. Pricing has not been publicly disclosed.

Short descriptiontext

Symphony Robotics is a Miami-based medical device company developing an MRI-guided, AI-controlled steerable micro-robotic platform for minimally invasive brain surgery, targeting neurosurgeons treating inaccessible brain tumors and drug-resistant epilepsy lesions. Technology is pre-FDA and pre-revenue.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersMiami, United States
HQ citystring
Miami
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
neurosurgical robotics, MRI-guided ablation, micro-robotic surgery, brain tumor treatment, minimally invasive neurosurgery
Industry4 codes
PRIMARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHDAAAIAC
Healthcare & Assistive Robotics
SECONDARYHLAHADAG
Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAKAIAC
Movement Disorders (Parkinson’s, Tremor, Dystonia)
NAICS code3 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Neurosurgical Robotics
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Micro-Robotic Platform Hardware Sales
TypeHardware Sales
Description

Pre-revenue company. The technology is currently investigational and under development, not yet cleared or approved by the FDA for clinical use. Once commercialized, the company is expected to generate revenue through the sale of its micro-robotic platform hardware to hospitals and surgical centers.

symphonyrobotics.health
2Professional Services and Training
TypeProfessional Services
Description

Potential revenue stream from training, implementation support, and ongoing technical support services for hospital and medical center customers adopting the technology.

massdevice.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Symphony Robotics develops an MRI-guided, magnetically actuated micro-robotic platform controlled by AI algorithms that navigates through the brain along non-linear, snake-like trajectories. The system enables neurosurgeons to deliver energy, perform biopsies, and precisely deliver therapeutic agents to multiple deep brain targets through a single minimally invasive entry point, addressing lesions previously considered inaccessible to conventional rigid surgical tools.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Single minimally invasive entry point replaces multiple invasive procedures for multi-target treatment
Product overview1 text field

Symphony Robotics offers a single unified product: its MRI-guided steerable micro-robotic platform. This platform combines AI-powered navigation with magnetically actuated flexible robotics to enable minimally invasive brain procedures. The system is designed to work in conjunction with existing surgical tools (such as laser ablation systems) to treat hard-to-reach brain pathologies. The company is backed by $12M+ in NIH and NSF funding and over a decade of research validation.

Product and service1 record
1MRI-Guided Steerable Micro-Robotic Platform
CategoryCore product
Description

An MRI-guided, magnetically actuated micro-robotic platform with AI-controlled navigation that bends, steers, and maneuvers through complex brain anatomy along non-linear, snake-like trajectories. Designed for neurosurgeons at hospitals and medical centers to deliver energy, perform biopsies, and precisely deliver therapeutic agents to multiple deep brain targets through a single minimally invasive entry point.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-01
Description

Strategic partnership to advance robotics for brain ablation surgery. Combines Symphony's MRI-guided, magnetically actuated micro-robotic arm with Monteris' NeuroBlate laser interstitial thermal therapy (LITT) system. Integrates AI-powered, flexible micro-robotic guidance with laser energy delivery to enable more precise, micro-invasive surgeries through non-linear trajectories within the brain. The collaboration aims to develop, launch, and commercialize the combined technology for treating brain tumors and drug-resistant epilepsy.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Brainlab is a major provider of neurosurgical navigation, planning, and intraoperative imaging software widely used in brain surgery. As an established incumbent in MRI-guided neurosurgical workflows, it is a broad competitor that could integrate or develop flexible robotic guidance capabilities.

TypeDirect peer
Description

Renishaw's Neuromate is a stereotactic neurosurgical robotic system used for brain biopsy, electrode placement, and other neurosurgical procedures. It competes in the same neurosurgical robotics category Symphony targets and represents a direct precedent for robotic neurosurgery platforms.

TypeEmerging player
Description

Globus Medical's ExcelsiusGPS is a robotic navigation platform expanding into cranial and spine procedures. As a growing surgical robotics player extending into neurosurgery, it represents an emerging competitor to Symphony's neurosurgical robotics focus.

TypeEmerging player
Description

Penumbra develops neurovascular and minimally invasive neurosurgical technologies, including aspiration and embolization systems. It is an emerging player in the broader minimally invasive neurosurgery market that could overlap with Symphony's targeted therapy delivery applications.

TypeDirect peer
Description

Monteris Medical manufactures the NeuroBlate laser interstitial thermal therapy (LITT) system used in MRI-guided brain ablation. It is Symphony Robotics' strategic co-development partner and the most directly comparable peer, as Symphony's micro-robotic arm is being integrated with NeuroBlate for the same neurosurgical ablation procedures.

TypeBroad incumbent
Description

Zimmer Biomet's ROSA robotic platform is used across neurosurgical and orthopedic procedures. As an established surgical robotics incumbent with neurosurgical applications, it is a broad peer competing for the same hospital capital purchasing cycles.

7Carl Zeiss (ZEISS Surgical Microscopy)
TypeBroad incumbent
TypeBroad incumbent
Description

Stryker offers neurosurgical instruments, navigation, and the MAKO surgical robot platform. It is a broad incumbent with both neurosurgical and adjacent robotic surgery assets that could compete with or acquire capabilities similar to Symphony's.

TypeBroad incumbent
Description

Medtronic offers StealthStation surgical navigation for neurosurgery and the Hugo surgical robot platform. Its neurosurgical navigation installed base and capital resources make it a broad incumbent that competes for neurosurgical procedure volumes and could develop competing MRI-guided robotic capabilities.

TypeDirect peer
Description

Synaptive Medical provides neurosurgical visualization, planning, and robotic-assisted surgery tools (e.g., Modus V, BrightMatter). It directly competes in MRI-based neurosurgical workflows and represents a comparable emerging neurosurgical technology peer.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Symphony Robotics

Neurosurgical Roboticssymphonyrobotics.health

Symphony Robotics is a Miami-based medical device company developing an MRI-guided, AI-controlled steerable micro-robotic platform for minimally invasive brain surgery, targeting neurosurgeons treating inaccessible brain tumors and drug-resistant epilepsy lesions. Technology is pre-FDA and pre-revenue.

What Symphony Robotics does

Symphony Robotics is a Miami-based, privately held medical device company developing an MRI-guided, magnetically actuated micro-robotic platform for neurosurgical applications. The company's core product is described as the world's first MRI-guided steerable micro-robotic system capable of navigating the brain along non-linear, snake-like trajectories, controlled by AI algorithms. The flexible robotic arm is designed to bend, steer, and maneuver through complex brain anatomy to reach lesions previously considered inaccessible via conventional rigid surgical instruments, enabling energy delivery, biopsies, and targeted therapeutic agent delivery through a single minimally invasive entry point. The platform targets neurosurgeons and brain surgery centers treating patients with irregularly shaped or hard-to-reach brain pathologies, including brain tumors and drug-resistant epilepsy.

The technology remains investigational and has not been cleared or approved by the U.S. Food and Drug Administration. The company has been validated through more than a decade of research and has received over $12 million in cumulative non-dilutive grant funding from the National Institutes of Health (NIH) and National Science Foundation (NSF). In October 2025, Symphony Robotics entered a strategic partnership with Monteris Medical to combine its MRI-guided micro-robotic arm with Monteris' NeuroBlate laser interstitial thermal therapy (LITT) system for treating brain tumors and drug-resistant epilepsy. The company is led by Founder and CEO Mordechai Avisar and Chief Medical Officer Neil Martin, with a headcount of 1-10 employees.

The business model is pre-commercial. Once FDA clearance is obtained, Symphony Robotics is expected to generate revenue primarily through direct enterprise sales of its micro-robotic platform hardware to hospitals and neurosurgical centers, with potential supplemental revenue from training, implementation, and technical support services. Distribution will likely be executed through direct sales to major neurosurgical centers, with the Monteris Medical partnership potentially providing an additional channel via NeuroBlate's installed base. Pricing has not been publicly disclosed.

Symphony Robotics firmographics

Firmographics
Name
Symphony Robotics
Legal name
Symphony Robotics
Website
https://symphonyrobotics.health
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
Symphony Robotics is a Miami-based medical device company developing an MRI-guided, AI-controlled steerable micro-robotic platform for minimally invasive brain surgery, targeting neurosurgeons treating inaccessible brain tumors and drug-resistant epilepsy lesions. Technology is pre-FDA and pre-revenue.
Ownership category
akta.pro rank

Symphony Robotics industry classification

Industry
Product category
Neurosurgical Robotics
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Surgical and Medical Instrument Manufacturing (339112)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHDAAAIAC
Healthcare & Assistive Robotics
SECONDARYHLAHADAG
Surgical Navigation, Tracking & Intraoperative Guidance (Ortho/Neuro/ENT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAKAIAC
Movement Disorders (Parkinson’s, Tremor, Dystonia)

Keywords

  • Neurosurgical robotics
  • MRI-guided ablation
  • Micro-robotic surgery
  • Brain tumor treatment
  • Minimally invasive neurosurgery

Where Symphony Robotics is headquartered

Location

Headquarters

HQ city
Miami
HQ country
United States
HQ region
North America

Markets served

Symphony Robotics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

  1. Micro-Robotic Platform Hardware Sales: Pre-revenue company. The technology is currently investigational and under development, not yet cleared or approved by the FDA for clinical use. Once commercialized, the company is expected to generate revenue through the sale of its micro-robotic platform hardware to hospitals and surgical centers.
  2. Professional Services and Training: Potential revenue stream from training, implementation support, and ongoing technical support services for hospital and medical center customers adopting the technology.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Symphony Robotics product offering

Product offering

Core offering

Symphony Robotics develops an MRI-guided, magnetically actuated micro-robotic platform controlled by AI algorithms that navigates through the brain along non-linear, snake-like trajectories. The system enables neurosurgeons to deliver energy, perform biopsies, and precisely deliver therapeutic agents to multiple deep brain targets through a single minimally invasive entry point, addressing lesions previously considered inaccessible to conventional rigid surgical tools.

Product overview

Symphony Robotics offers a single unified product: its MRI-guided steerable micro-robotic platform. This platform combines AI-powered navigation with magnetically actuated flexible robotics to enable minimally invasive brain procedures. The system is designed to work in conjunction with existing surgical tools (such as laser ablation systems) to treat hard-to-reach brain pathologies. The company is backed by $12M+ in NIH and NSF funding and over a decade of research validation.

Differentiator

Problem solved

Functional benefit

Products and services

  • MRI-Guided Steerable Micro-Robotic Platform An MRI-guided, magnetically actuated micro-robotic platform with AI-controlled navigation that bends, steers, and maneuvers through complex brain anatomy along non-linear, snake-like trajectories. Designed for neurosurgeons at hospitals and medical centers to deliver energy, perform biopsies, and precisely deliver therapeutic agents to multiple deep brain targets through a single minimally invasive entry point.

Quantifiable outcome

  • Single minimally invasive entry point replaces multiple invasive procedures for multi-target treatment

Companies that use Symphony Robotics

Customer profile

Segments3 records

Ideal customer profiles2 records

Symphony Robotics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

Symphony Robotics partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Monteris MedicalcoreStrategic or Co-development Partner · 1 October 2025Strategic partnership to advance robotics for brain ablation surgery. Combines Symphony's MRI-guided, magnetically actuated micro-robotic arm with Monteris' NeuroBlate laser interstitial thermal therapy (LITT) system. Integrates AI-powered, flexible micro-robotic guidance with laser energy delivery to enable more precise, micro-invasive surgeries through non-linear trajectories within the brain. The collaboration aims to develop, launch, and commercialize the combined technology for treating brain tumors and drug-resistant epilepsy.

Scale indicators5 records

Recent moves4 records

Expansion highlights4 records

Symphony Robotics competitors and assessment

Company assessment

Broad incumbents

  • Brainlab: Brainlab is a major provider of neurosurgical navigation, planning, and intraoperative imaging software widely used in brain surgery. As an established incumbent in MRI-guided neurosurgical workflows, it is a broad competitor that could integrate or develop flexible robotic guidance capabilities.
  • Zimmer Biomet (ROSA): Zimmer Biomet's ROSA robotic platform is used across neurosurgical and orthopedic procedures. As an established surgical robotics incumbent with neurosurgical applications, it is a broad peer competing for the same hospital capital purchasing cycles.
  • Carl Zeiss (ZEISS Surgical Microscopy):
  • Stryker (Neurosurgical portfolio): Stryker offers neurosurgical instruments, navigation, and the MAKO surgical robot platform. It is a broad incumbent with both neurosurgical and adjacent robotic surgery assets that could compete with or acquire capabilities similar to Symphony's.
  • Medtronic (StealthStation / Hugo): Medtronic offers StealthStation surgical navigation for neurosurgery and the Hugo surgical robot platform. Its neurosurgical navigation installed base and capital resources make it a broad incumbent that competes for neurosurgical procedure volumes and could develop competing MRI-guided robotic capabilities.

Direct peers

  • Renishaw (Neuromate): Renishaw's Neuromate is a stereotactic neurosurgical robotic system used for brain biopsy, electrode placement, and other neurosurgical procedures. It competes in the same neurosurgical robotics category Symphony targets and represents a direct precedent for robotic neurosurgery platforms.
  • Monteris Medical: Monteris Medical manufactures the NeuroBlate laser interstitial thermal therapy (LITT) system used in MRI-guided brain ablation. It is Symphony Robotics' strategic co-development partner and the most directly comparable peer, as Symphony's micro-robotic arm is being integrated with NeuroBlate for the same neurosurgical ablation procedures.
  • Synaptive Medical: Synaptive Medical provides neurosurgical visualization, planning, and robotic-assisted surgery tools (e.g., Modus V, BrightMatter). It directly competes in MRI-based neurosurgical workflows and represents a comparable emerging neurosurgical technology peer.

Emerging players

  • Globus Medical (ExcelsiusGPS): Globus Medical's ExcelsiusGPS is a robotic navigation platform expanding into cranial and spine procedures. As a growing surgical robotics player extending into neurosurgery, it represents an emerging competitor to Symphony's neurosurgical robotics focus.
  • Penumbra: Penumbra develops neurovascular and minimally invasive neurosurgical technologies, including aspiration and embolization systems. It is an emerging player in the broader minimally invasive neurosurgery market that could overlap with Symphony's targeted therapy delivery applications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights6 records

Customer concentration

Symphony Robotics social profiles

Digital presence

Symphony Robotics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Symphony Robotics leadership team

Management profile

Number of profiles

Profiles2 records

Symphony Robotics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Symphony Robotics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Symphony Robotics

What does Symphony Robotics do?

Symphony Robotics develops an MRI-guided, magnetically actuated micro-robotic platform controlled by AI algorithms that navigates through the brain along non-linear, snake-like trajectories. The system enables neurosurgeons to deliver energy, perform biopsies, and precisely deliver therapeutic agents to multiple deep brain targets through a single minimally invasive entry point, addressing lesions previously considered inaccessible to conventional rigid surgical tools.

Is Symphony Robotics a public or private company?

Symphony Robotics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Symphony Robotics founded?

Symphony Robotics was founded in -1. It employs 1 to 10 people.

Where is Symphony Robotics based?

Symphony Robotics is headquartered in Miami, United States, in the North America region.

How does Symphony Robotics make money?

Two revenue lines are on record. Micro-Robotic Platform Hardware Sales are the primary driver. The others are professional Services and Training.

Who are Symphony Robotics's main competitors?

Broad incumbents on record are Brainlab, Zimmer Biomet (ROSA), Carl Zeiss (ZEISS Surgical Microscopy), Stryker (Neurosurgical portfolio) and Medtronic (StealthStation / Hugo). Direct peers are Renishaw (Neuromate), Monteris Medical and Synaptive Medical. Emerging players are Globus Medical (ExcelsiusGPS) and Penumbra.

Does Symphony Robotics have an API?

No public API is recorded for Symphony Robotics.

What industry is Symphony Robotics in?

Symphony Robotics's product category is Neurosurgical Robotics. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HDAAAIAC, Healthcare & Assistive Robotics. Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comKey Strategic Trends and Emerging Changes Shaping the Micro Robots Market LandscapeThe Business Research Company published a market report projecting the micro robots market to reach $5.54 billion by 2030, growing at a 12.6% CAGR, driven by demand for targeted drug delivery, AI adoption, and precision manufacturing. In October 2025, Monteris Medical partnered with Symphony Robotics to develop an AI-powered micro-robotic platform for brain laser ablation to enhance neurosurgical procedures. In December 2025, the University of Pennsylvania and the University of Michigan unveiled the world's smallest fully programmable autonomous microrobots, measuring approximately 200 × 300 × 50 micrometers and produced at roughly one cent each.EIN PresswireGlobal Tumor Ablation Market Size to Reach USD 1,579.7 Million by 2034 | Growth Forecast, 2026–2034Fortune Business Insights released a market research report projecting the global tumor ablation market to grow from USD 846.8 million in 2025 to USD 1,579.7 million by 2034, representing a compound annual growth rate of 7.2%. The report identifies increasing global cancer incidence, technological advancements in ablation devices, and growing preference for minimally invasive procedures as primary growth drivers. Key industry developments include Medtronic's June 2025 FDA approval for its Visualase V2 MRI-Guided Laser Ablation System and Monteris Medical's October 2025 collaboration with Symphony Robotics for MRI-guided brain ablation procedures.MassDeviceMonteris, Symphony Robotics collab on AI-driven microrobots for brain ablationMonteris Medical and Symphony Robotics announced a strategic partnership to advance robotics for brain ablation surgery, combining Symphony's MRI-guided, magnetically actuated micro-robotic arm with Monteris' NeuroBlate laser interstitial thermal therapy (LITT) system. The collaboration aims to integrate Symphony's AI-powered, flexible micro-robotic guidance with Monteris' laser energy delivery to enable more precise, micro-invasive surgeries through non-linear trajectories within the brain. Symphony Robotics expects the partnership to accelerate development, market launch, and commercialization of the combined technology for treating brain tumors and drug-resistant epilepsy.PR NewswireMonteris Medical and Symphony Robotics Announce Strategic Collaboration to Launch AI-Driven Micro-Robotic Platform for Laser Ablation in the BrainMonteris Medical and Symphony Robotics announced a strategic partnership to integrate Symphony's AI-driven micro-robotic technology with Monteris' laser ablation systems for brain surgery. The collaboration aims to enhance surgical precision by enabling curved pathways and real-time MRI-guided motion planning for treating complex brain tumors and epilepsy. Symphony's robotic arm technology, currently under development and not yet FDA-approved, is designed to operate within the MRI bore to improve outcomes for challenging anatomical targets.PR NewswireSymphony Robotics Welcomes Neurosurgery Leader Dr. Neil A. Martin as Chief Medical Officer to Revolutionize Glioblastoma Treatment with First-Ever MRI-Steerable Micro-RoboticsSymphony Robotics appointed Dr. Neil A. Martin as Chief Medical Officer to lead its engine-free micro-robotic platform for glioblastoma treatment. Preclinical studies show up to three times the volumetric coverage versus existing technologies. The company plans beta site testing later this year.